102
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gabapentinoid prescriptions for neuropathic and musculoskeletal pain in Lebanon

, , , , ORCID Icon &
Article: FSO960 | Received 28 Sep 2023, Accepted 17 Jan 2024, Published online: 16 Apr 2024

References

  • Rhodes J, Erickson MA, Tagawa A, Niswander C. Orthopedics. In: Current Diagnosis & Treatment: Pediatrics, 24e [Internet]. Hay William W Jr, Levin MJ, Deterding RR, Abzug MJ ( Eds). [ cited 2019 Apr 23). McGraw-Hill Education, NY, USA (2018).
  • Hasan A, Pearl A, Daher M, Saleh KJ. Patient genetic heterogeneities acting as indicators of post-operative pain and opioid requirement in orthopedic surgery: a systematic review. J. Opioid Manag. 20(1), 77–85 (2023).
  • Daher M, Sebaaly A. Coronavirus disease and the musculoskeletal system: a narrative review. Egyptian Orthop. J. 57(3), 221–224 (2023).
  • Daher M, Roukoz S, Pearl A, Saleh K. Osteoid osteoma of the wrist: recent advances. Hand Surg. Rehabil. 42(5), 386–391 (2023).
  • Daher M, Ghoul A, Salameh B-L et al. Management of the 4th of August explosion in an orthopedics department. Egypt Orthop. J. 58(2), 83–88 (2023).
  • Daher M, Ghoul A, Salameh B-L et al. Metacarpals and phalanges malunion: a narrative review. Egypt Orthop. J. 58(2), 53–59 (2023).
  • Sampognaro G, Harrell R. Multimodal postoperative pain control after orthopaedic surgery. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL) (2023).
  • Yasaei R, Katta S, Saadabadi A. Gabapentin. (2023).
  • Cross AL, Viswanath O, Sherman AL. Pregabalin. (2023).
  • Anantharamu T, Govind MA. Managing chronic pain: are gabapentinoids being misused? Pain Manag. 8(5), 309–311 (2018).
  • Baftiu A, Lima MH, Svendsen K, Larsson PG, Johannessen SI, Landmark CJ. Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation. Eur. J. Clin. Pharmacol. 75(8), 1153–1160 (2019).
  • Johansen ME. Gabapentinoid Use in the United States 2002 Through 2015. JAMA Intern. Med. 178(2), 292–294 (2018).
  • Montastruc F, Loo SY, Renoux C. Trends in first gabapentin and pregabalin prescriptions in primary care in the United Kingdom, 1993–2017. JAMA 320(20), 2149–2151 (2018).
  • Rees S. Gabapentin and pregabalin in the pain setting: all you need to know. Nurse Prescr. 16(7), 332–340 (2018).
  • Enke O, New HA, New CH et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. CMAJ 190(26), E786–E793 (2018).
  • Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern. Med. 179(5), 695–701 (2019).
  • Fabritius ML, Strøm C, Koyuncu S et al. Benefit and harm of pregabalin in acute pain treatment: a systematic review with meta-analyses and trial sequential analyses. Br. J. Anaesth. 119(4), 775–791 (2017).
  • Murnion BP. Neuropathic pain: current definition and review of drug treatment. Aust. Prescr. 41(3), 60–63 (2018).
  • Mack A. Examination of the evidence for off-label use of gabapentin. J. Manag. Care Pharm. 9(6), 559–568 (2003).
  • Egunsola O, Wylie CE, Chitty KM, Buckley NA. Systematic review of the efficacy and safety of gabapentin and pregabalin for pain in children and adolescents. Anesth. Analg. 128(4), 811–819 (2019).
  • Chen O, Cadwell JB, Matsoukas K, Hagen J, Afonso AM. Perioperative gabapentin usage in pediatric patients: a scoping review. Paediatr. Anaesth. 33(8), 598–608 (2023).
  • Girdler SJ, Lieber AM, Cho B, Cho SK, Allen AK, Ranade SC. Perioperative pain protocols following surgery for adolescent idiopathic scoliosis: a snapshot of current treatments utilized by attending orthopedic surgeons. Spine Deform. 12(1), 57–65 (2023).
  • Calandre EP, Rico-Villademoros F, Slim M. Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Rev. Neurother. 16(11), 1263–1277 (2016).
  • Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin. Ther. 25(1), 81–104 (2003).
  • Robertson K, Marshman LAG, Plummer D. Pregabalin and gabapentin for the treatment of sciatica. J. Clin. Neurosci. 26, 1–7 (2016).
  • Pérez C, Navarro A, Saldaña MT, Masramón X, Rejas J. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: findings from a cost-consequences analysis in a nested case-control study. Clin. Ther. 32(7), 1357–1370 (2010).
  • Shanthanna H, Gilron I, Rajarathinam M et al. Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 14(8), e1002369 (2017).
  • Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin. Pharmacokinet. 49(10), 661–669 (2010).
  • Kharasch ED, Eisenach JC. Wherefore Gabapentinoids?: was there rush too soon to judgment? Anesthesiology 124(1), 10–12 (2016).
  • Jongen JLM, Hans G, Benzon HT, Huygen F, Hartrick CT. Neuropathic pain and pharmacological treatment. Pain Pract. 14(3), 283–295 (2014).
  • Giakas JA, Israel HA, Ali AH, Kaar SG. Does the addition of post-operative gabapentin reduce the use of narcotics after orthopedic surgery? Phys Sportsmed. doi: 10.1080/00913847.2023.2246177 (2023).
  • Zhang D-A, Brenn B, Cho R, Samdani A. Shriners Spine Study Group, Poon SC. Effect of gabapentin on length of stay, opioid use, and pain scores in posterior spinal fusion for adolescent idiopathic scoliosis: a retrospective review across a multi-hospital system. BMC Anesthesiol. 23(1), 10 (2023).
  • Daniels AH, Daher M, Singh M et al. The case for operative efficiency in adult spinal deformity surgery: impact of operative time on complications, length of stay, alignment, fusion rates, and patient reported outcomes. Spine (Phila. Pa. 1976) 49(5), doi: 10.1097/BRS.0000000000004873 (2023).
  • Gabapentin for adults with neuropathic pain: a review of the clinical efficacy and safety. Ottawa Can. Agency Drugs Technol. Heal. (2015).
  • Morrison EE, Sandilands EA, Webb DJ. Gabapentin and pregabalin: do the benefits outweigh the harms? J. R. Coll. Physicians Edinb. 47(4), 310–313 (2017).